Ownership

Matthew Ros - Insider Trading & Ownership

Entity: Individual
Location: C/O Epizyme, Inc., 400 Technology Square, Cambridge, MA
Summary: The estimated net worth of Matthew Ros is at least $157K dollars as of January 21, 2025. Matthew Ros is the Executive Vice President, Chief Strategy & Business Officer of Epizyme, Inc. and owns shares of Epizyme, Inc. stock worth about $157K.
All Insider Reports: All Insider Reports

Ownership of Matthew Ros

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
EPZM	Epizyme, Inc.	Executive Vice President, Chief Strategy & Business Officer	$157K			Aug 16, 2021
COGT	Cogent Biosciences, Inc.	Director				Jun 5, 2024
VSTM	Verastem, Inc.	Chief Operating Officer				Jan 14, 2025

Showing 1 to 3 of 3 entries

Insider Transactions Reported by Matthew Ros:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.